1 |
LA MENDOLA D, TRINCAVELLI M L, MARTINI C. Angiogenesis in Disease[J]. Int J Mol Sci, 2022, 23(18):10962. doi:10.3390/ijms231810962
doi: 10.3390/ijms231810962
|
2 |
EELEN G, TREPS L, LI X, et al. Basic and Therapeutic Aspects of Angiogenesis Updated[J]. Circ Res, 2020, 127(2):310-329. doi:10.1161/circresaha.120.316851
doi: 10.1161/circresaha.120.316851
|
3 |
NARASIMHAN B, NARASIMHAN H, LORENTE-ROS M, et al. Therapeutic angiogenesis in coronary artery disease: A review of mechanisms and current approaches[J]. Expert Opin Investig Drugs, 2021, 30(9):947-963. doi:10.1080/13543784.2021.1964471
doi: 10.1080/13543784.2021.1964471
|
4 |
WEI L, SUN X, FAN C, et al. The pathophysiological mechanisms underlying diabetic retinopathy[J]. Front Cell Dev Biol, 2022, 10:963615. doi:10.3389/fcell.2022.963615
doi: 10.3389/fcell.2022.963615
|
5 |
LUCAS M, LUCAS A. Neuritin, unmasked as a checkpoint for the pathogenesis of allergy and autoimmunity[J]. Clin Transl Immunology, 2021, 10(5):e1290. doi:10.1002/cti2.1290
doi: 10.1002/cti2.1290
|
6 |
NAEVE G S, RAMAKRISHNAN M, KLMER R, et a1. Neuritin: A gene induced by neural activity and neurotrophins that promotes neuritogenesis[J]. Proc Natl Acad SCi U S A, 1997, 94(6): 2648-2653. doi:10.1073/pnas.94.6.2648
doi: 10.1073/pnas.94.6.2648
|
7 |
WAN K, MAO F, LI Q, et al. Neuritin-overexpressing transgenic mice demonstrate enhanced neuroregeneration capacity and improved spatial learning and memory recovery after ischemia-reperfusion injury [J]. Aging (Albany NY), 2020, 13(2):2681-2699. doi:10.18632/aging.202318
doi: 10.18632/aging.202318
|
8 |
XU H, DONG J, LI Y, et al. Neuritin has a neuroprotective role in the rat model of acute ischemia stroke by inhibiting neuronal apoptosis and NLRP3 inflammasome[J]. J Stroke Cerebrovasc Dis, 2023, 32(12):107391. doi:10.1016/j.jstrokecerebrovasdis.2023.107391
doi: 10.1016/j.jstrokecerebrovasdis.2023.107391
|
9 |
KOJIMA N, SHIOJIRI N, SAKAI Y, et al. Expression of neuritin during liver maturation and regeneration[J]. FEBS Lett, 2005, 579(21): 4562-4566. doi:10.1016/j.febslet.2005.07.015
doi: 10.1016/j.febslet.2005.07.015
|
10 |
DONG H, LUO X, NIU Y, et al. Neuritin 1 expression in human normal tissues and its association with various human cancers[J]. Int J Clin Exp Pathol,2018, 11(4):1956-1964.
|
11 |
LIANG M, SONG Y, ZHANG W, et al. Expression of Neuritin in human lung squamous cell carcinoma[J]. Transl Cancer Res, 2019, 8(6):2389-2395. doi:10.21037/tcr.2019.09.52
doi: 10.21037/tcr.2019.09.52
|
12 |
KAMADA S, IKEDA K, SUZUKI T, et al. Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma[J]. Front Oncol, 2021, 11:758503. doi:10.3389/fonc.2021.758503
doi: 10.3389/fonc.2021.758503
|
13 |
YAO J J, ZHAO Q R, LU J M, et al. Functions and the related signaling pathways of the neurotrophic factor neuritin[J]. Acta Pharmacol Sin, 2018, 39(9):1414-1420. doi:10.1038/aps.2017.197
doi: 10.1038/aps.2017.197
|
14 |
SENRUNG A, TRIPATHI T, JANJUA D, et al. Chick chorioallantoic membrane: A valuable 3D in vivo model for screening nanoformulations for tumor antiangiogenic therapeutics[J]. Int J Dev Biol, 2023, 67(4):115-135. doi:10.1387/ijdb.230198pb
doi: 10.1387/ijdb.230198pb
|
15 |
RIBATTI D, TAMMA R, ANNESE T. Chorioallantoic membrane vascularization. A meta-analysis[J]. Exp Cell Res,2021, 405(2):112716. doi:10.1016/j.yexcr.2021.112716
doi: 10.1016/j.yexcr.2021.112716
|
16 |
DURANOVA H, KUZELOVA L, BOROTOVA P, et al. Human Umbilical Vein Endothelial Cells as a Versatile Cellular Model System in Diverse Experimental Paradigms: An Ultrastructural Perspective[J]. Microsc Microanal, 2024, 30(3):419-439. doi:10.1093/mam/ozae048
doi: 10.1093/mam/ozae048
|
17 |
HAN Y, CHEN X H, SHI F M, et al. CPGl5, a new factor up-regulated after ischemic brain injury, contributes to neuronal network re-establishment after glutamate-induced injury[J]. Neurotrauma, 2007, 24: 722-731. doi:10.1089/neu.2006.0174
doi: 10.1089/neu.2006.0174
|
18 |
WANG X, LIU C, XU F, et al. Effects of neuritin on the migration, senescence and proliferation of human bone marrow mesenchymal stem cells[J]. Cell Mol Biol Lett, 2015, 20(3):466-474. doi:10.1515/cmble-2015-0026
doi: 10.1515/cmble-2015-0026
|
19 |
SHALAEVA A Y, KOZIN V V. Cell Proliferation Indices in Regenerating Alitta virens (Annelida, Errantia)[J]. Cells, 2023, 12(10):1354. doi:10.3390/cells12101354
doi: 10.3390/cells12101354
|
20 |
ZHANG Z, LIU Y, ZHOU J. Neuritin Promotes Bone Marrow-Derived Mesenchymal Stem Cell Migration to Treat Diabetic Peripheral Neuropathy[J]. Mol Neurobiol, 2022, 59(11):6666-6683. doi:10.1007/s12035-022-03002-2
doi: 10.1007/s12035-022-03002-2
|
21 |
刘京敏, 史晨辉, 王维山, 等. 局部注射Neuritin促进骨折愈合的实验研究[J]. 石河子大学学报(自然科学版), 2012, 30 (6): 720-724.
|
22 |
魏建国, 段东明, 井一涵, 等. 不同浓度生长因子对人脐静脉内皮细胞增殖影响的实验研究[J]. 实用医学杂志, 2021, 37 (23): 2977-2983.
|
23 |
KUCZYNSKI E A, VERMEULEN P B, PEZZELLA F, et al. Vessel co-option in cancer[J]. Nat Rev Clin Oncol, 2019, 16(8):469–493. doi:10.1038/s41571-019-0181-9
doi: 10.1038/s41571-019-0181-9
|
24 |
彭一鹏, 周晓飞, 王剑, 等. 肿瘤坏死因子α诱导蛋白3相互作用蛋白1调控核因子κB信号通路在IDH野生型胶质瘤中的作用机制[J]. 实用医学杂志, 2022, 38(16):2002-2008. doi:10.3969/j.issn.1006-5725.2022.16.004
doi: 10.3969/j.issn.1006-5725.2022.16.004
|
25 |
TU J, LIANG H, LI C, et al. The application and research progress of anti-angiogenesis therapy in tumor immunotherapy[J]. Front Immunol, 2023, 14:1198972. doi:10.3389/fimmu.2023.1198972
doi: 10.3389/fimmu.2023.1198972
|
26 |
HUANG M, LIN Y, WANG C, et al. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects[J]. Drug Resist Updat, 2022, 64:100849. doi:10.1016/j.drup.2022.100849
doi: 10.1016/j.drup.2022.100849
|